| pubmed-article:15049187 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15049187 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15049187 | lifeskim:mentions | umls-concept:C0027530 | lld:lifeskim |
| pubmed-article:15049187 | lifeskim:mentions | umls-concept:C0024232 | lld:lifeskim |
| pubmed-article:15049187 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:15049187 | lifeskim:mentions | umls-concept:C1514474 | lld:lifeskim |
| pubmed-article:15049187 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:15049187 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:15049187 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:15049187 | pubmed:dateCreated | 2004-3-30 | lld:pubmed |
| pubmed-article:15049187 | pubmed:abstractText | The aim of this study is to analyze the results of treatment results and prognostic factors related to clinical and treatment characteristics in patients with neck lymph nodes metastases from the unknown primary site. 90 patients with pathology proven cancer metastases in the neck lymph nodes from the unknown primary site were treated between 1984-1998. Most of them (58 patients--63%) had advanced disease in lymph nodes N3. The rest had stage N2abc before initial treatment. 40 patients underwent combined treatment--surgery and definitive radiotherapy. 3 patients had induction chemotherapy followed by resection and radiotherapy. 30 patients received radiotherapy alone or radiotherapy and chemotherapy. In 7 cases chemotherapy after surgical resection were used. Curves of overall survival were estimated using Kaplan-Meier method. Analysis of the prognostic factors was performed using Cox's multivariate proportional risk model. 5 years overall survival probability was 24%. In the group of patients who underwent surgery and radiotherapy probability of 5 years overall survival was 43%. In patients who received radiotherapy alone or radiotherapy and chemotherapy probability of 5 year overall survival was 2%. Multivariate analysis showed significant influence of the performance status (PS--WHO scale), sex and stage N3 on overall survival. The patients with PS 0-1 had better prognosis comparing with PS 2-3 (p < 0.001). Male had worse prognosis then female (p = 0.05). N3 stage reduced overall survival in comparison to N2abc (p = 0.06). In the analysis of disease free survival N3-stage was the only independent factor concerning with poor outcome (p = 0.03). Patients who had surgery followed by radiotherapy had better prognosis. Poor performance status, sex-male and N3 stage were identified as the important factors influencing overall survival. N3-stage was an independent factor influencing disease free survival. | lld:pubmed |
| pubmed-article:15049187 | pubmed:language | pol | lld:pubmed |
| pubmed-article:15049187 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15049187 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15049187 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15049187 | pubmed:issn | 0030-6657 | lld:pubmed |
| pubmed-article:15049187 | pubmed:author | pubmed-author:KraszewskaEwa... | lld:pubmed |
| pubmed-article:15049187 | pubmed:author | pubmed-author:SzutkowskiZbi... | lld:pubmed |
| pubmed-article:15049187 | pubmed:author | pubmed-author:KaweckiAndrze... | lld:pubmed |
| pubmed-article:15049187 | pubmed:author | pubmed-author:Wasilewska-Te... | lld:pubmed |
| pubmed-article:15049187 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15049187 | pubmed:volume | 57 | lld:pubmed |
| pubmed-article:15049187 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15049187 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15049187 | pubmed:pagination | 861-6 | lld:pubmed |
| pubmed-article:15049187 | pubmed:dateRevised | 2007-12-28 | lld:pubmed |
| pubmed-article:15049187 | pubmed:meshHeading | pubmed-meshheading:15049187... | lld:pubmed |
| pubmed-article:15049187 | pubmed:meshHeading | pubmed-meshheading:15049187... | lld:pubmed |
| pubmed-article:15049187 | pubmed:meshHeading | pubmed-meshheading:15049187... | lld:pubmed |
| pubmed-article:15049187 | pubmed:meshHeading | pubmed-meshheading:15049187... | lld:pubmed |
| pubmed-article:15049187 | pubmed:meshHeading | pubmed-meshheading:15049187... | lld:pubmed |
| pubmed-article:15049187 | pubmed:meshHeading | pubmed-meshheading:15049187... | lld:pubmed |
| pubmed-article:15049187 | pubmed:meshHeading | pubmed-meshheading:15049187... | lld:pubmed |
| pubmed-article:15049187 | pubmed:meshHeading | pubmed-meshheading:15049187... | lld:pubmed |
| pubmed-article:15049187 | pubmed:meshHeading | pubmed-meshheading:15049187... | lld:pubmed |
| pubmed-article:15049187 | pubmed:meshHeading | pubmed-meshheading:15049187... | lld:pubmed |
| pubmed-article:15049187 | pubmed:meshHeading | pubmed-meshheading:15049187... | lld:pubmed |
| pubmed-article:15049187 | pubmed:meshHeading | pubmed-meshheading:15049187... | lld:pubmed |
| pubmed-article:15049187 | pubmed:meshHeading | pubmed-meshheading:15049187... | lld:pubmed |
| pubmed-article:15049187 | pubmed:meshHeading | pubmed-meshheading:15049187... | lld:pubmed |
| pubmed-article:15049187 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:15049187 | pubmed:articleTitle | [Lymphatic metastasis in the neck from unknown primary. Analysis of treatment results and prognostic factors]. | lld:pubmed |
| pubmed-article:15049187 | pubmed:affiliation | Klinika Nowotworów G?owy i Szyi Centrum Onkologii Instytutu im. M. Sk?odowskiej-Curie w Warszawie. | lld:pubmed |
| pubmed-article:15049187 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15049187 | pubmed:publicationType | English Abstract | lld:pubmed |
